Concepedia

Takayuki Miyazaki

TM

Statistics

Publications

6

Citations

207

H-Index

6

Active since

1997

Affiliations

Eisai (Japan)(Current)

Takayuki Miyazaki is an author at Eisai (Japan) specializing in lipid nanoparticles, mrna lipid nanoparticles, and pharmacy.

ORCID

Publications per year

1997–2024

6

Publications

6

Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates

Yuta Suzuki, Takayuki Miyazaki, Hiroki Muto et al. · Molecular Therapy — Nucleic Acids · 2022 · 75 citations · Full text

, , +17

Lipid nanoparticle-targeted mRNA formulation as a treatment for ornithine-transcarbamylase deficiency model mice

Kazuto Yamazaki, Kenji Kubara, Satoko Ishii et al. · Molecular Therapy — Nucleic Acids · 2023 · 39 citations · Full text

, , +17

Lymph node macrophages drive innate immune responses to enhance the anti-tumor efficacy of mRNA vaccines

Kenji Kubara, Kazuto Yamazaki, Takayuki Miyazaki et al. · Molecular Therapy · 2024 · 39 citations · Full text

, , +17

Understanding the Manufacturing Process of Lipid Nanoparticles for mRNA Delivery Using Machine Learning

Shinya Sato, Syusuke Sano, Hiroki Muto et al. · Chemical and Pharmaceutical Bulletin · 2024 · 25 citations · Full text

, , +17

A Poster Creating Support System to Reflect Kansei

Takayuki Miyazaki, Masafumi Hagiwara · Transactions of Information Processing Society of Japan · 1997 · 15 citations

, , +4

1–5 of 6